- Hologic press release (NASDAQ:HOLX): Q1 Non-GAAP EPS of $1.07 beats by $0.14.
- Revenue of $1.07B (-26.97% Y/Y) beats by $60M.
- Diagnostics revenue decreased (41.2%), or (39.4%) in constant currency, primarily driven by lower sales of COVID-19 assays compared to the prior year period.
- Cash flow from operations remained very strong in the first quarter at $253.4 million. In addition, the Company repurchased 1.5 million shares of its stock for $100 million in the quarter.
Recommended For You
More Trending News
See More »